Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients

NCT01986127 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped slow recruitment

Conditions

Crohn's Disease

Interventions

DRUG: Adalimumab
DRUG: placebo

Sponsor

Sara Varea

Collaborators

[object Object]